- Trade name: Galvus
- Generic name: Vildagliptin
- Drug class: Dipeptidyl Peptidase-4 Inhibitors
- Manufacturer: Novartis Pharmaceuticals UK Ltd
What is Galvus?
Galvus is an oral treatment for people with type 2 diabetes that has been recently approved. It is often taken in conjunction with other anti-diabetes medications like metformin, sulphonylureas and thiazolidinediones.
You should be advised on the dosage of Galvus by a healthcare professional. Usually, Galvus is prescribed as a once-daily drug and may be combined with other medications.
Is Galvus Effective?
So far, Galvus has proven in clinical trials to add efficiency when used in combination with other anti-diabetic medication. It was found to significantly reduce blood glucose levels.
Who Can’t Take Galvus?
People that have type 2 diabetes along with liver problems and liver impairment shouldn’t take Galvus. People should have their liver monitored at the start of every Galvus course.
Patients with renal impairment or congestive heart failure should also avoid Galvus.
Your healthcare professional will be able to establish whether or not Galvus is a suitable medication for you.
The reported side effects of Galvus are as follows:
- Weight gain